术后瘢痕组织和肿瘤复发模型的制备及磁共振成像研究
|
摘要
目的建立术后瘢痕组织病理模型,探讨术后瘢痕组织病理模型的可行性,研究术后瘢痕组织病理模型的病理学表现。材料与方法9只新西兰大白兔,体重2-4kg,采用速眠新Ⅱ肌肉注射麻醉,0.2ml/kg体重。麻醉满意后,对兔子后大腿局部备皮,在无菌环境下,钝性分离并部分离断其后大腿的肌梭,植入折叠后面积大小约3x3cm2的生理盐水浸泡过的无菌纱布,常规消毒后缝合、包扎。术后5天内每天对切口消毒一次,并肌肉注射硫酸庆大霉素2mg/kg体重,防止术后感染。植入纱布后两周,麻醉,在无菌条件下,取出植入的纱布。观察3周后,取瘢痕组织进行病理学检查。对取出的瘢痕组织行大体病理学观察后,制成厚度为5umm的组织切片行H-E染色,在显微镜下观察并进行显微摄影。结果9只兔子术后瘢痕组织的病理模型均制备成功,大体病理学观察,增生斑痕组织大小在1.3-2.6cm范围,表现为以白色为主的淡红色,质地较韧。显微镜下观察,瘢痕组织形态不规则,由增生的成纤维细胞构成,胶原纤维大量沉积,呈条索状或漩涡状分布,一定数量的小血管残存,与人体组织的增生性瘢痕组织表现相似。尚有少量的炎性细胞。结论钝性分离并局部离断肌肉组织,植入无菌纱布刺激瘢痕组织增生是一种制备术后瘢痕组织模型的有效造模方法,制备的瘢痕组织在病理上与人体的增生性瘢痕结构类似。
目的研究术后瘢痕组织模型的磁共振表现,对照分析术后瘢痕组织的MRI表现与病理学表现,研究它们的相关性。材料与方法20只新西兰大白兔,在无菌环境下,钝性分离并部分离断其后大腿的肌梭,植入生理盐水浸泡过折叠后面积约3×3cm2的无菌纱布。植入纱布后两周,取出植入的纱布。观察3周后,利用GE Excite 1.5T超导磁共振仪进行磁共振平扫、磁共振弥散加权成像和动态对比增强磁共振成像,扫描完成后,取瘢痕组织进行病理学检查。结果20只兔子瘢痕组织模型均制备成功。镜下观察,瘢痕组织细胞排列紊乱,形态不规则,主要由大量的成纤维细胞、胶原纤威吓一定数量的小血管构成。磁共振平扫,瘢痕组织均表现为以中等信号为主的稍短T1长T2信号,内部信号欠均匀。DWI图上,瘢痕组织呈高信号,在ADC图上,瘢痕组织表现为等信号或稍低信号。b=200s／mm2时瘢痕组织和正常肌肉组织的ADC值差异无统计学意义；在b=400s／mm2和b=600s／mm2时,瘢痕组织和正常肌肉组织的ADC值的差异有统计学意义(P<0.05)。随着b值增加,ADC值有所减小。动态增强扫描,时间-信号强度曲线12例呈缓慢上升型,8例曲线升支较陡直,升至峰值后持续在相对较高水平。瘢痕组织和正常肌肉组织的时间-信号强度曲线有显著性差异。结论术后瘢痕组织的磁共振表现具有良性病变的一些表现,瘢痕组织的磁共振表现在一定程度上可以反应其病理特点。
目的制备术后瘢痕组织和肿瘤复发的模型,研究术后瘢痕组织和肿瘤复发的氢质子磁共振波谱表现。材料与方法20只新西兰大白兔,采用速眠新Ⅱ肌肉注射麻醉。麻醉后,取兔子的右后大腿,在无菌环境下,钝性分离并部分离断其后大腿的肌梭,植入折叠后面积大小约3×3cm2的两块生理盐水浸泡过的无菌纱布。在同次手术中,将VX2肿瘤组织混悬液1ml,接种于兔子左后大腿肌肉的肌梭内。术后对切口消毒,并肌肉注射抗生素,以防感染。两周后,在无菌条件下,取出植入的纱布。同次手术中,将肿瘤切除,局部保留少许肿瘤包膜,术后抗感染。取出纱布3周后可触及明显的软组织肿块,后进行磁共振平扫和利用PRESS序列进行单体素1H-MRS采集。磁共振扫描仪采用GE 1.5T Excite磁共振扫描仪,扫描线圈用头线圈或3英寸表面线圈。
结果20只兔子术后瘢痕组织和肿瘤复发模型的制备均成功。瘢痕组织形态不规则,大量的成纤维细胞聚集,胶原纤维沉积,一定数量的小血管残存,有少量的炎性细胞浸润。复发的肿瘤组织,瘤细胞呈巢状或不规则弥漫性分布,细胞核大而染色深,异形性明显,瘤间质有大量不成熟的毛细血管和纤维组织。所有兔子正常肌肉组织1H-MRS均表现为Cho峰最小,位于3.2ppm处；Lipid峰最高,位于1.4-1.6ppm处；Cr峰较高,位于3.02ppm处。瘢痕组织中有17例1H-MRS采集成功,表现为在1.4-1.6ppm处均有高大的脂质峰,其中5例在3.2ppm处有小的Cho峰和3.02ppm处有小的Cr峰,12例未见Cho峰和Cr峰。3例扫描不成功。复发的VX2肿瘤在1H-MRS均表现为：Cho峰增高,明显高于肌肉组织；Lipid峰较低,低于正常肌肉组织；Cr峰较低,在谱线上不易辨认或者与Cho峰融合。结论兔子正常肌肉、复发的VX2肿瘤组织和术后增生的瘢痕组织之间的1H-MRS存在一定的差异,这种差异是术后瘢痕组织和复发的肿瘤之间代谢差异的反映,JH-MRS有望用于进行术后瘢痕组织和肿瘤复发的鉴别诊断。
目的研究术后瘢痕组织和肿瘤复发模型的磁共振灌注表现,对照分析其磁共振灌注表现和病理学表现,探讨磁共振灌注成像鉴别术后瘢痕组织和肿瘤复发的价值。
材料与方法20只新西兰大白兔,体重2-4kg,麻醉后,取兔子的右后大腿,在无菌环境下,钝性分离并部分离断其后大腿的肌梭,植入折叠后面积大小约3×3cm2的两块生理盐水浸泡过的无菌纱布。在同次手术中,将VX2肿瘤组织混悬液1ml,接种于兔子左后大腿的肌梭内。术后注射抗生素防感染。两周后,在无菌条件下,取出植入的纱布。同次手术中,将肿瘤切除,局部保留少许肿瘤包膜,术后抗感染。取出纱布3周后可触及明显的软组织肿块。采用GEExicitel.5T超导磁共振仪,利用3D-FSPGR序列进行动态对比增强磁共振灌注成像。对比剂采用GD-DTPA,比较术后瘢痕组织和复发肿瘤的灌注曲线,计算两者的Emax值和Es值,比较两者的差异。结果20只兔子术后瘢痕组织和肿瘤复发模型均制备成功。瘢痕组织内成纤维细胞聚集,胶原纤维沉积,有一定数量的管壁完整的小血管残存。复发的肿瘤组织,瘤细胞丰富密集,表现为巢状或不规则弥漫性分布,细胞核大染色深,异形性明显,间质内含有大量不成熟的毛细血管和一定量的纤维组织。动态增强扫描11例瘢痕组织的强化曲线呈缓慢上升型,9例瘢痕组织的强化曲线升支快速上升,到达峰值后呈相对平坦的曲线。复发的肿瘤组织的强化曲线7例呈快速上升后又快速下降的曲线,13例呈快速上升后缓慢下降的曲线。瘢痕组织的Emax值为57.63±15.02,Es值为0.62±0.35；肿瘤组织的Emax值为125.26±27.61,Es值为1.38±0.47。两者差异具有统计学意义(p<0.05)。结论术后瘢痕组织和复发的肿瘤MRI灌注曲线有统计学意义的差异,这种差异是两者病理学差异的反映。MRI灌注是鉴别术后瘢痕组织和肿瘤复发的较好方法。
Objective:To prepare the postoperative scar models and research it's pathology findings.
Methods:Postoperative scar models were made in the hind thigh of 9 New Zealand white rabbits. After anesthetize with Su Mian XinⅡby intramuscular injection, In the sterile environment, we blunt dissected and partly mutilate the hind thigh muscles. Then we folded and packed a asepsis saline sooked gauze of 3cm2 between the muscle bellies. The gentamicin sulfate was used to prevent infection after operation. Two weeks later, the gauze was surgically removed in aseptic conditions. After 3 weeks of observation, we took the scar tissue to do pathology examination and make microphotograph under the microscope.
Results:All the 9 postoperative scar models were successful. The size of the scar tissue was about 1.3-2.6cm, The main color was white. Under the microscope, a lot fibroblasts were hyperplasia and collagen fibrils deposited in the scar tissue. In the scar, there was some small vessels remnant and some phlegmasia cells infiltrated. Conclusion:To blunt dissected the muscles and packed gauze between the muscle bellies is a good method to make the postoperative scar models. The pathology appearances of the models were similar to the hyperplastic scar.
Objective:To establish experimental animal models of postoperative scar tissue and determine whether MRI and pathology of postoperative scar are associated. Material
and Methods:Postoperative scar models were made in the hind thigh of 20 New Zealand white rabbits. In the sterile environment, we blunt dissected and partly mutilate the post thigh muscles after anesthetize. Then we folded and packed a asepsis saline sooked gauze of 3cm2 between the muscle bellies. The gentamicin sulfate was used to prevent infection after operation. Two weeks later, the gauze was surgically removed in aseptic conditions. After 3 weeks of observation, we used Ge Excite 1.5T superconducting MR device to made plain MRI scanning、DWI and DCE-MRI. We took the scar tissue to do pathology examination after scanning. Results:All the 20 postoperative scar models were successful. Under the microscope, a lot fibroblasts were hyperplasia and collagen fibrils deposited in the scar tissue. In the scar, there was some small vessels remnant. The scar tissue appeared middling T1 and long T2 signal in the plain scanning. On DWI, the scar tissue appeared high signal. On ADC imaging, the scar tissue appeared middle or slightly low signal. When we used b=200s/mm2, the difference of ADC were not statistically significant between the scar and muscle. But at b=400s/mm2 and b=600s/mm2, the difference of ADC were statistically significant between the scar and muscle. On DCE-MRI, the time-signal intensity curve was ascended slowly in 12 cases. In the other 8 cases, the time-signal intensity curve was keeping a relative high level after ascended the maximum intensity. The difference of the time-signal intensity curve was statistically significant between the scar and muscle. Conclusion:The.findings of post operative scar tissue were similar to some benign lesions on MRI. The appearances of post operative scar tissue on MRI were the reflection of their pathology.
Objective:Our purpose is to establish experimental animal models of postoperative scar and recurrent tumor, and to investigate in vivo proton magnetic resonance spectroscopy (1H MRS) features of the models. Material and Methods:We used 20 New Zealand white rabbits to establish the models. In the sterile environment, we blunt dissected and partly mutilate the post right thigh muscles of the rabbits after anesthetize. Then we folded and packed two asepsis saline sooked gauzes of 3cm2 between the muscle bellies. At the same time, we implanted with 1ml VX2 tumor tissue suspension in the left proximal thighs. The gentamicin sulfate was used to prevent infection after operation. Two weeks later, the gauzes and the tumor was surgically removed in aseptic conditions. But the peplos of the tumor was remained partly. After 3 weeks of observation, We performed MRI and 1H MRS and analyzed the 1H MRS features of postoperative scar tissue and recurrent VX2 tumors in all rabbits. Results:Twenty models were all successful. A lot fibroblasts were hyperplasia and collagen fibrils deposited in the scar tissue. In the scar, there was some small vessels remnant. In the recurrent tumors, the tumor cells were distributed diffusion or like nests. The nuclear of the recurrent tumor was obviously heteromorphy. Among the interstitial substances of the recurrent tumor, there was a lot of immature vascular hyperplasia. Cho, Cr and lipid peak were seen in the in vivo 1H MRS of normal muscle. The Lip peak was the highest, the Cr was higher, and the Cho was low. The 1H MRS of 17 cases was successfully acquired in the 20 postoperative scar models. Five had the very low Cho and Cr peak of the 17 cases. There were no Cho and Cr in the other 12 cases. The Lip and the Cho peak of all the recurrent tumors were obviously high. But the Cr was low. The Lip was lower than the muscle and the Cho was higher than the muscle. Conclusion:The postoperative scar and recurrent VX2 tumor of rabbits showed great difference in 1H MRS. In vivo 1H MRS may reveal the difference of metabolism information in the postoperative scar and recurrent tumor. Maybe 1H MRS can be used to the differential diagnosis between the postoperative scar tissue and the recurrent tumor.
Objective:To study the DCE-MRI findings of the postoperative scar tissue and the recurrent tumor models. Correlate the DCE-MRI findings and the pathology findings of the postoperative scar tissue and recurrent tumor to analysis their associativity. To investigate the differentiation diagnosis value of DCE-MRI in postoperative scar and recurrent tumor.
Material and Methods:20 New Zealand white rabbits were used to establish the models. In the sterile environment, we blunt dissected and partly mutilate the post right thigh muscles of the rabbits after anesthetize. Then we folded and packed two asepsis saline sooked gauzes of 3cm2 between the muscle bellies. At the same time, we implanted with lml VX2 tumor tissue suspension in the left proximal thighs. The gentamicin sulfate was used to prevent infection after operation. Two weeks later, the gauzes and the tumor was surgically removed in aseptic conditions. But the capsule of the tumor was remained partly. After 3 weeks of observation, We performed DCE-MRI used 3D-FSPGR series and analyzed the DCE-MRI features of postoperative scar tissue and recurrent VX2 tumors in all rabbits. We used GD-DTPA as the contrast media. To compare the time-signal intensity curve and the Emax, Es value between the postoperative scar tissue and the recurrent tumor.
Results:Twenty models were all successful. A lot fibroblasts were hyperplasia and collagen fibrils deposited in the scar tissue. In the scar, there was some small vessels remnant. In the recurrent tumors, the tumor cells were distributed diffusion or like nests. The nuclear of the recurrent tumor was obviously heteromorphy. Among the interstitial substances of the recurrent, there was a lot of immature vascular hyperplasia. The time-intensity curve of scar tissue in 11 rabbits ascended slowly but descended not obvious. In 9 rabbits, The time-signal intensity curve of scar tissue ascended quickly and keep a relative high level after reaching the peak value. The time-signal ntensity curve of recurrent tumor ascended suddenly and descended slowly after reaching the peak value in 13 rabbits. In 7 rabbits, The time-signal intensity curve of recurrent tumor ascended and descended quickly. The Emax and Es value of postoperative scar respectively were 57.63±15.02 and 0.62±0.35. The Emax and Es value of recurrent tumor respectively were 125.26±27.61 and 1.38±0.47.Their difference was statistically significant (p<0.05). Conclusion:The difference of the maximum percentage of enhancement (Emax) and enhancement slope(Es) between postoperative scar tissue and recurrent tumor are all significant. The difference is the reflection of their pathology. MR perfusion weighted imaging may be efficacious method to distinguish postoperative scar tissue and recurrence tumor.
目的研究术后瘢痕组织模型的磁共振表现,对照分析术后瘢痕组织的MRI表现与病理学表现,研究它们的相关性。材料与方法20只新西兰大白兔,在无菌环境下,钝性分离并部分离断其后大腿的肌梭,植入生理盐水浸泡过折叠后面积约3×3cm2的无菌纱布。植入纱布后两周,取出植入的纱布。观察3周后,利用GE Excite 1.5T超导磁共振仪进行磁共振平扫、磁共振弥散加权成像和动态对比增强磁共振成像,扫描完成后,取瘢痕组织进行病理学检查。结果20只兔子瘢痕组织模型均制备成功。镜下观察,瘢痕组织细胞排列紊乱,形态不规则,主要由大量的成纤维细胞、胶原纤威吓一定数量的小血管构成。磁共振平扫,瘢痕组织均表现为以中等信号为主的稍短T1长T2信号,内部信号欠均匀。DWI图上,瘢痕组织呈高信号,在ADC图上,瘢痕组织表现为等信号或稍低信号。b=200s／mm2时瘢痕组织和正常肌肉组织的ADC值差异无统计学意义；在b=400s／mm2和b=600s／mm2时,瘢痕组织和正常肌肉组织的ADC值的差异有统计学意义(P<0.05)。随着b值增加,ADC值有所减小。动态增强扫描,时间-信号强度曲线12例呈缓慢上升型,8例曲线升支较陡直,升至峰值后持续在相对较高水平。瘢痕组织和正常肌肉组织的时间-信号强度曲线有显著性差异。结论术后瘢痕组织的磁共振表现具有良性病变的一些表现,瘢痕组织的磁共振表现在一定程度上可以反应其病理特点。
目的制备术后瘢痕组织和肿瘤复发的模型,研究术后瘢痕组织和肿瘤复发的氢质子磁共振波谱表现。材料与方法20只新西兰大白兔,采用速眠新Ⅱ肌肉注射麻醉。麻醉后,取兔子的右后大腿,在无菌环境下,钝性分离并部分离断其后大腿的肌梭,植入折叠后面积大小约3×3cm2的两块生理盐水浸泡过的无菌纱布。在同次手术中,将VX2肿瘤组织混悬液1ml,接种于兔子左后大腿肌肉的肌梭内。术后对切口消毒,并肌肉注射抗生素,以防感染。两周后,在无菌条件下,取出植入的纱布。同次手术中,将肿瘤切除,局部保留少许肿瘤包膜,术后抗感染。取出纱布3周后可触及明显的软组织肿块,后进行磁共振平扫和利用PRESS序列进行单体素1H-MRS采集。磁共振扫描仪采用GE 1.5T Excite磁共振扫描仪,扫描线圈用头线圈或3英寸表面线圈。
结果20只兔子术后瘢痕组织和肿瘤复发模型的制备均成功。瘢痕组织形态不规则,大量的成纤维细胞聚集,胶原纤维沉积,一定数量的小血管残存,有少量的炎性细胞浸润。复发的肿瘤组织,瘤细胞呈巢状或不规则弥漫性分布,细胞核大而染色深,异形性明显,瘤间质有大量不成熟的毛细血管和纤维组织。所有兔子正常肌肉组织1H-MRS均表现为Cho峰最小,位于3.2ppm处；Lipid峰最高,位于1.4-1.6ppm处；Cr峰较高,位于3.02ppm处。瘢痕组织中有17例1H-MRS采集成功,表现为在1.4-1.6ppm处均有高大的脂质峰,其中5例在3.2ppm处有小的Cho峰和3.02ppm处有小的Cr峰,12例未见Cho峰和Cr峰。3例扫描不成功。复发的VX2肿瘤在1H-MRS均表现为：Cho峰增高,明显高于肌肉组织；Lipid峰较低,低于正常肌肉组织；Cr峰较低,在谱线上不易辨认或者与Cho峰融合。结论兔子正常肌肉、复发的VX2肿瘤组织和术后增生的瘢痕组织之间的1H-MRS存在一定的差异,这种差异是术后瘢痕组织和复发的肿瘤之间代谢差异的反映,JH-MRS有望用于进行术后瘢痕组织和肿瘤复发的鉴别诊断。
目的研究术后瘢痕组织和肿瘤复发模型的磁共振灌注表现,对照分析其磁共振灌注表现和病理学表现,探讨磁共振灌注成像鉴别术后瘢痕组织和肿瘤复发的价值。
材料与方法20只新西兰大白兔,体重2-4kg,麻醉后,取兔子的右后大腿,在无菌环境下,钝性分离并部分离断其后大腿的肌梭,植入折叠后面积大小约3×3cm2的两块生理盐水浸泡过的无菌纱布。在同次手术中,将VX2肿瘤组织混悬液1ml,接种于兔子左后大腿的肌梭内。术后注射抗生素防感染。两周后,在无菌条件下,取出植入的纱布。同次手术中,将肿瘤切除,局部保留少许肿瘤包膜,术后抗感染。取出纱布3周后可触及明显的软组织肿块。采用GEExicitel.5T超导磁共振仪,利用3D-FSPGR序列进行动态对比增强磁共振灌注成像。对比剂采用GD-DTPA,比较术后瘢痕组织和复发肿瘤的灌注曲线,计算两者的Emax值和Es值,比较两者的差异。结果20只兔子术后瘢痕组织和肿瘤复发模型均制备成功。瘢痕组织内成纤维细胞聚集,胶原纤维沉积,有一定数量的管壁完整的小血管残存。复发的肿瘤组织,瘤细胞丰富密集,表现为巢状或不规则弥漫性分布,细胞核大染色深,异形性明显,间质内含有大量不成熟的毛细血管和一定量的纤维组织。动态增强扫描11例瘢痕组织的强化曲线呈缓慢上升型,9例瘢痕组织的强化曲线升支快速上升,到达峰值后呈相对平坦的曲线。复发的肿瘤组织的强化曲线7例呈快速上升后又快速下降的曲线,13例呈快速上升后缓慢下降的曲线。瘢痕组织的Emax值为57.63±15.02,Es值为0.62±0.35；肿瘤组织的Emax值为125.26±27.61,Es值为1.38±0.47。两者差异具有统计学意义(p<0.05)。结论术后瘢痕组织和复发的肿瘤MRI灌注曲线有统计学意义的差异,这种差异是两者病理学差异的反映。MRI灌注是鉴别术后瘢痕组织和肿瘤复发的较好方法。
Objective:To prepare the postoperative scar models and research it's pathology findings.
Methods:Postoperative scar models were made in the hind thigh of 9 New Zealand white rabbits. After anesthetize with Su Mian XinⅡby intramuscular injection, In the sterile environment, we blunt dissected and partly mutilate the hind thigh muscles. Then we folded and packed a asepsis saline sooked gauze of 3cm2 between the muscle bellies. The gentamicin sulfate was used to prevent infection after operation. Two weeks later, the gauze was surgically removed in aseptic conditions. After 3 weeks of observation, we took the scar tissue to do pathology examination and make microphotograph under the microscope.
Results:All the 9 postoperative scar models were successful. The size of the scar tissue was about 1.3-2.6cm, The main color was white. Under the microscope, a lot fibroblasts were hyperplasia and collagen fibrils deposited in the scar tissue. In the scar, there was some small vessels remnant and some phlegmasia cells infiltrated. Conclusion:To blunt dissected the muscles and packed gauze between the muscle bellies is a good method to make the postoperative scar models. The pathology appearances of the models were similar to the hyperplastic scar.
Objective:To establish experimental animal models of postoperative scar tissue and determine whether MRI and pathology of postoperative scar are associated. Material
and Methods:Postoperative scar models were made in the hind thigh of 20 New Zealand white rabbits. In the sterile environment, we blunt dissected and partly mutilate the post thigh muscles after anesthetize. Then we folded and packed a asepsis saline sooked gauze of 3cm2 between the muscle bellies. The gentamicin sulfate was used to prevent infection after operation. Two weeks later, the gauze was surgically removed in aseptic conditions. After 3 weeks of observation, we used Ge Excite 1.5T superconducting MR device to made plain MRI scanning、DWI and DCE-MRI. We took the scar tissue to do pathology examination after scanning. Results:All the 20 postoperative scar models were successful. Under the microscope, a lot fibroblasts were hyperplasia and collagen fibrils deposited in the scar tissue. In the scar, there was some small vessels remnant. The scar tissue appeared middling T1 and long T2 signal in the plain scanning. On DWI, the scar tissue appeared high signal. On ADC imaging, the scar tissue appeared middle or slightly low signal. When we used b=200s/mm2, the difference of ADC were not statistically significant between the scar and muscle. But at b=400s/mm2 and b=600s/mm2, the difference of ADC were statistically significant between the scar and muscle. On DCE-MRI, the time-signal intensity curve was ascended slowly in 12 cases. In the other 8 cases, the time-signal intensity curve was keeping a relative high level after ascended the maximum intensity. The difference of the time-signal intensity curve was statistically significant between the scar and muscle. Conclusion:The.findings of post operative scar tissue were similar to some benign lesions on MRI. The appearances of post operative scar tissue on MRI were the reflection of their pathology.
Objective:Our purpose is to establish experimental animal models of postoperative scar and recurrent tumor, and to investigate in vivo proton magnetic resonance spectroscopy (1H MRS) features of the models. Material and Methods:We used 20 New Zealand white rabbits to establish the models. In the sterile environment, we blunt dissected and partly mutilate the post right thigh muscles of the rabbits after anesthetize. Then we folded and packed two asepsis saline sooked gauzes of 3cm2 between the muscle bellies. At the same time, we implanted with 1ml VX2 tumor tissue suspension in the left proximal thighs. The gentamicin sulfate was used to prevent infection after operation. Two weeks later, the gauzes and the tumor was surgically removed in aseptic conditions. But the peplos of the tumor was remained partly. After 3 weeks of observation, We performed MRI and 1H MRS and analyzed the 1H MRS features of postoperative scar tissue and recurrent VX2 tumors in all rabbits. Results:Twenty models were all successful. A lot fibroblasts were hyperplasia and collagen fibrils deposited in the scar tissue. In the scar, there was some small vessels remnant. In the recurrent tumors, the tumor cells were distributed diffusion or like nests. The nuclear of the recurrent tumor was obviously heteromorphy. Among the interstitial substances of the recurrent tumor, there was a lot of immature vascular hyperplasia. Cho, Cr and lipid peak were seen in the in vivo 1H MRS of normal muscle. The Lip peak was the highest, the Cr was higher, and the Cho was low. The 1H MRS of 17 cases was successfully acquired in the 20 postoperative scar models. Five had the very low Cho and Cr peak of the 17 cases. There were no Cho and Cr in the other 12 cases. The Lip and the Cho peak of all the recurrent tumors were obviously high. But the Cr was low. The Lip was lower than the muscle and the Cho was higher than the muscle. Conclusion:The postoperative scar and recurrent VX2 tumor of rabbits showed great difference in 1H MRS. In vivo 1H MRS may reveal the difference of metabolism information in the postoperative scar and recurrent tumor. Maybe 1H MRS can be used to the differential diagnosis between the postoperative scar tissue and the recurrent tumor.
Objective:To study the DCE-MRI findings of the postoperative scar tissue and the recurrent tumor models. Correlate the DCE-MRI findings and the pathology findings of the postoperative scar tissue and recurrent tumor to analysis their associativity. To investigate the differentiation diagnosis value of DCE-MRI in postoperative scar and recurrent tumor.
Material and Methods:20 New Zealand white rabbits were used to establish the models. In the sterile environment, we blunt dissected and partly mutilate the post right thigh muscles of the rabbits after anesthetize. Then we folded and packed two asepsis saline sooked gauzes of 3cm2 between the muscle bellies. At the same time, we implanted with lml VX2 tumor tissue suspension in the left proximal thighs. The gentamicin sulfate was used to prevent infection after operation. Two weeks later, the gauzes and the tumor was surgically removed in aseptic conditions. But the capsule of the tumor was remained partly. After 3 weeks of observation, We performed DCE-MRI used 3D-FSPGR series and analyzed the DCE-MRI features of postoperative scar tissue and recurrent VX2 tumors in all rabbits. We used GD-DTPA as the contrast media. To compare the time-signal intensity curve and the Emax, Es value between the postoperative scar tissue and the recurrent tumor.
Results:Twenty models were all successful. A lot fibroblasts were hyperplasia and collagen fibrils deposited in the scar tissue. In the scar, there was some small vessels remnant. In the recurrent tumors, the tumor cells were distributed diffusion or like nests. The nuclear of the recurrent tumor was obviously heteromorphy. Among the interstitial substances of the recurrent, there was a lot of immature vascular hyperplasia. The time-intensity curve of scar tissue in 11 rabbits ascended slowly but descended not obvious. In 9 rabbits, The time-signal intensity curve of scar tissue ascended quickly and keep a relative high level after reaching the peak value. The time-signal ntensity curve of recurrent tumor ascended suddenly and descended slowly after reaching the peak value in 13 rabbits. In 7 rabbits, The time-signal intensity curve of recurrent tumor ascended and descended quickly. The Emax and Es value of postoperative scar respectively were 57.63±15.02 and 0.62±0.35. The Emax and Es value of recurrent tumor respectively were 125.26±27.61 and 1.38±0.47.Their difference was statistically significant (p<0.05). Conclusion:The difference of the maximum percentage of enhancement (Emax) and enhancement slope(Es) between postoperative scar tissue and recurrent tumor are all significant. The difference is the reflection of their pathology. MR perfusion weighted imaging may be efficacious method to distinguish postoperative scar tissue and recurrence tumor.
引文
[1]沈华,沈忠礼,王永春,等,斑痕内切除后即时放疗治疗瘢痕疙瘩的临床分析,中国美容医学,2009,18(1)：5-7.
[2]刘利兵,于军,张学策,等,新西兰兔烫伤模型的建立,第四军医大学学报,2009,30(1)：86-88.
[3]李荟元,刘建波.在瘢痕研究中建立动物模型的探索[J].中华创伤杂志,2001,17：190-192.
[4]张彤,夏群力,郑捷,一种增生性瘢痕动物模型的建立,中国皮肤性病学杂志,2008,22(3)：146-148.
[5]Dirk A., Hans J, Alf theisen, et al, Standardized qualitative evaluation of scar tissue properties in an animal wound healing model, Wound REP REG 2003;11:150-157.
[6]Joon Woo Lee, Woo Kyung Moon, Hanns-Joachim Weinmann, et. Al, Contrast-enhanced MR Imaging of Postoperative Scars and VX2 Carcinoma in Rabbits:Comparison of Macromolecular Contrast Agent and Gadopentetate Dimeglumine, Radiology,2003,229 (1):132-139
[7]M Hardy, The biology of scar formation, physical therapy,1989,69(12):1014-1024.
[8]Xinhong Lim, Ichiro T, Tomoko Tateya, et al, Immediate inflammatory response and scar formation in wound vocal folds, Rhinology and Laryngology,2006,115 (12):921-929.
[9]Willem M., Monica C.T., Magda M.W., et al, Potential cellular and molecular causes of hypertrophic scar formation, burns,2009,35:15-29
[10]Steven R. Beanes, Catherine Dang,et al, Skin repair and scar formation:the central role of TGF-β,Cambridge University Press expert reviews in molecular medicine, 2003,5(3):1-11.
[11]李玉林主编,病理学,北京,人民卫生出版社第7版,2008.01,22-23.
[12]王西樵,刘英开,毛志刚,等,增生性瘢痕中成纤维细胞生物学功能变化与微血管病理改变的研究,创伤外科杂志,2007,9(4)：311-314.
[1]李广帅,陈言汤,牛扶幼等,病理性瘢痕的发病机制,郑州大学学报,2006.41(6)：1025.1027.
[2]3.Maureen Hardy, The biology of scar formation, Physical Therapy,1989, 69 (12):1014-1024.
[3]Nonomura Y, Yasumoto M, Yoshimura R, et, al, Relationship between bone marrow cellularity and apparent diffusion coefficient, J Magn Reson Imaging,2001,13: 757-760.
[4]Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions:application to diffusion and perfusion in neurologic disorders.Radiology,1986,161, (2):401-407;
[5]Thomas DL, Lythgoe MF, Pell GS, et al. The measurement of diffusion and perfusion in biological systems using magnetic resonance imaging. Phys Med Biol,2000, 45(8):97-138;
[6]曾洪武,王培军,磁共振扩散加权与弥散张量成像原理分析及比较,中国医学影像技术,2005,21(12)：1945-1947.
[7]Kucharczy J, Roberts T, Moseley EE, et al. Contrast-enhanced perfusion-sensitive MR imaging in the diagnosis of cerebrovascular disorders [J].Magn Reson Imaging,1993,3 (1):241-245.
[8]De-Cresp igny AJ, Howard D, DA rceuil H, et al. Dynamic contrast enhanced MRI of Implanted VX2 tumors in rabbit muscle:Comparison of Gd-DTPA and NMS60 [J]. Magn Reson Imaging,1999,17:1297.
[9]邢宁,蔡祖龙,赵绍宏,等,孤立性肺结节的灌注曲线分析,中国医学影像杂志,2009,17：89-91.
[10]Verstraete KL, Deene Y, Roels H,et al, Benign and malignant musculoskeletal lesions:dynamic contrast-enhanced MR imaging-parametric "first-pass" imaging depict tissue vascularization and perfusion[J]. Radiology,1994,192 (3):835-843.
[11]Aslihan S, Elif Ayanoglu, Nihat Kodalli, et al, Dynamic contrast-enhanced MRI in the differentiation of post treatment fibrosis from recurrent carcinoma of the head and neck, Journal of Clinical Imaging,2005,29:307-312
[1]李克、于同刚,磁共振波谱技术在肌骨疾病中的应用,中国医学计算机成像杂志,2003,9(5)：332-337.
[2]刘红军,张云亭,刘松龄等.高级别星形细胞瘤与脑单发转移瘤的1H-MRS鉴别.放射学实践,2004,19(3)：183-186.
[3]张磊,金真,刘彦君等.肌细胞内脂质与胰岛素抵抗关系的1H-MRS研究.放射学实践,2005,20(2)：106-109；
[4]姚宏伟,高秀香,赵梅仙,等,傅里叶变换红外光谱与核磁共振波谱对结直肠 癌诊断价值的初步研究,中国微创外科杂志,2009,9(1)：59-61.
[5]Mueller-Lisse UG, Scherr MK, Klinikumder U.M, et, al, Proton MRS of the prostate, Eur J Radiol,2007;63 (3):351-360.
[6]Jurgen Machanna, Norbert Stefan, Fritz Schick,1H MR spectroscopy of skeletal muscle, liver and bone marrow, Eur J Radiol,2008,67 (2):275-284
[7]Brechtel K, Jacob S, Machann J, et al. Acquired Generalized Lipoatrophy(AGL): Highly Selective MR Lipid Imaging and Localized 1H-MRS[J]. J Magn Reson Imaging,2000,12(2):306-310;
[8]Towner RA, Foley LM, Painter DM, et al. Hepatocarcinogenesis tumor grading correlated wit h in vivo image guided 1H-NMR spect roscopy in a rat model. Toxicol Appl Pharmacol,2005,207:237-244.
[9]Ting YL, Sherr D, Degani H. Variations in energy and phospholipids metabolism in normal and cancer human mammary epithelial cells. Anticancer Res 1996; 16:1381-1388.
[10]Jackowski S. Cell cycle regulation.of membrane phospholipids metabolism. J Biol Chem 1996;271(34):20219-22.
[11]Rutkowski T, Tarnawski R, Sokol M, et al,1H-MR spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors. Int J Radiat Oncol Biol Phys,2003;56:1381-13899.
[12]Hyeon-Man B, Hon J. Y, Jeon-Hor C, et al, Quantitative correlation between 1H MRS and dynamic contrast-enhanced MRI of human breast cancer, Magnetic Resonance Imaging,2008,26:523-531
[13]Therese S, Kathrine R, Dag R.O, Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion weighted magnetic resonance imaging in a colorectal tumor model, Radiotherapy and Oncology,2007,85(2):187-194.
[1]Peter Boyle, Bernard Levin, http://www.iarc.fr/en/publications. World Cancer Report 2008.
[2]Thomas DL, Lythgoe MF, Pell GS, et al. The measurement of diffusion and perfusion in biological systems using magnetic resonance imaging. Phys Med Biol,2000, 45(8):97-138
[3]Cercignani M, Horsfield MA. The physical basis of diffusion weighted MRI. J Neurol Sci,2001,186[Supply 1]:11-14
[4]Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions:application to diffusion and perfusion in neurologic disorders.Radiology,1986,161, (2):401-407;
[5]Thomas DL, Lythgoe MF, Pell GS, et al. The measurement of diffusion and perfusion in biological systems using magnetic resonance imaging. Phys Med Biol,2000, 45(8):97-138;
[6]Brandao LA, Domingues RC著,刘筠主译.脑磁共振波谱成像,[M].天津：天津科技翻译出版公司,2005：2-5.
[7]Baslow MH, Suckow RF, Hungund BL. Effects of ethanol and of alcohol dehydrogenase inhibitors on the reduction of N-acetylaspartate levels of brain in mice in vivo:a search for substances that may have therapeutic vlaue in the treatmetn of Canavan disease. J Inherit Metab Dis,2000,23:684
[8]Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors:a multicenter study[J]. J Neurosurg,1996,84:449-548;
[9]齐滋华,李传福,马祥兴,等,3.0T31P-MRS对骨与软组织肿瘤的诊断价值,实用放射学杂志,2008,24(12)：1643-1647.
[10]Maris J, EvansA, Mclaughlin A, et al.31 P-NMR spectroscopic investigation of human neuroblastoma in situ[J]. N Engl JMed,1986,312 (23):1500-1505.
[11]吕衍春,孟悛非,磁共振灌注成像的原理及其在肿瘤诊断中的应用,国外医学临床放射学分册,1999,6：341-345.
[12]Koenraad L. V, Yves D. D, MSc H. Roels, et al, Benign and Malignant Musculoskeletal Lesions:Dynamic Contrast-enhanced MR Imaging Parametric "First-Pass" Images Depict Tissue Vascularization and Perfusion, Radiology 1994, 192 (3); 192:835-843
[13]Wang W, Campiche M, Micro vasculature of human colorectal epithelial tumor:an electron microscopic study, Vichows Arch A Pathol Anat Histopathol,1982; 397: 131-147.
[14]Jackson A, Kassner A, Zhu XP, Li KL. Reproducibility of T2* blood volume and vascular tortuosity maps in cerebral gliomas. J Magn Reson Imaging, 2001;14:510-516.
[15]Tanabel JL,Yongbi M, Branch C,et al. MR perfusion imaging in human brain using the UN-FAIR technigue:un-inverted flow-sensitive alternating inversion recovery.J Magn Reson Imaging,1999,9:761
[16]Bettina Siewert, Gottfried Schlaug, Robert R Edelman, et al, Comparison of EPISTAR and T sub 2*-weighted gadolinium-enhanced perfusion imaging in patients with acute cerebral ischemia, Neurology.1997,48 (3):673-679.
[17]TM Talavage, WB Edmister, PJ Ledden, et al, Quantitative assessment of auditory cortex responses induced by imager acoustic noise", Human Brain Mapping,1999, 7 (2):79-88,.
[18]Pickles MD, Gibbs P, Lowry M, Turnbull LW. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 2006;24:843-847.
[19]Zhao M, Pipe JG, Bonnett J, et al. Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. Br J Cancer 1996;73:61-4.
[20]Le Bihan D, Breton E, Lallemand D, et al.Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168:497-505.
[21]Chenevert TL, McKeever PE, Ross BD. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res1997;3:1457-66.
[22]Lemaire L, Howe FA, Rodrigues LM, et al. Assessment of induced rat mammary tumour response to chemotherapy using the apparent diffusion coefficient of tissue water as determined by diffusion-weighted 1H-NMR spectroscopy in vivo. MAGMA 1999;8:20-26.
[23]Moffat BA, Chenevert TL, Lawrence TS, et al. Functional diffusion map:a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA 2005; 102:5524-9.
[24]Theilmann RJ, Borders R, Trouard TP,et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 2004;6:831-839.
[25]Dzik-Jurasz A, Domenig C, George M, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. The Lancet 2002;360:307-308.
[26]Vanessa N, Scott IS, Fiona J, et al, Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer Gynecologic Oncology, (2008)111:213-220
[27]Khong PL, Kwong DL, Chan GC, et al, Diffusion tensor imaging for the detection and quantification of treatment induced white matter injury in children with medulloblastoma:a pilot study. AJNR 2003;24(4):734-40.
[28]Khong PL, Lucullus H.T. Leung, Amy S.M, et al, White Matter Anisotropy in Post-Treatment Childhood Cancer Survivors:Preliminary Evidence of Association With Neurocognitive Function J Clin Oncol,2004,24 (2):884-890.
[29]DJ Manton, A Chaturvedi, A Hubbard,et al, Neoadjuvant chemotherapy in breast cancer:early response prediction with quantitative MR imaging and spectroscopy, Br J Cancer,2006,94 (3):427-435
[30]Isobe T,Matsumura A, Anno I, et al. Changes in 1H-MRS in glioma patients before and after irradiation:the significance of quantitative analysis of choline-containing compounds[J]. No Shinkei Geka,2003; 31 (2):167-172.
[31]Tzika AA, ZurakowskiD, Poussaint TY, et al. Proton magnetic spectroscop ic imaging of the child's brain:the response of tumors to treatment [J]. N euroradiology, 2001;43(6):169-177.
[32]杜泽涵,茹祥斌,李光玉,等.紫杉醇治疗小鼠S180肉瘤的体内31P-MRS研究[J].波谱学杂志,1999,16(1)：5-10.
[33]Moller HE, Vermathen P, Rummeny E, et al. In vivo 31P-MRS of human musculoskeletal tumors as a measure of response to chemotherapy. NMR Biomed, 1996,9(8):347-358;
[34]Elena V. B, Shu Li, Anna M. B, et al, Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers, Journal of Controlled Release,2010, Jan 13. [E pub ahead of print].
[35]T.M. Krupka, B.D. Weinberg, H. Wu, et al, Effect of intratumoral injection of carboplatin combined with pluronic P85 or L61 on experimental colorectal carcinoma in rats, Exp. Biol. Med. (Maywood),2007,232(7):950-957.
[36]Jacquemier JD, Penault-Llorca FM, Bertucci F, et al. Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy:a multiparametric and immuno histochemical analysis. J Pathol 1998;184:130-5.
[37]Van Der Woude HJ, Bloem JL, Verstraete KL, et al. Osteosarcoma and Ewing sarcoma after neoadhuvant chemotherapy:value of dynamic MR imaging in detecting viable tumor before surgery. AJR,1995,65:593-598;
[38]Takeshi N, Masahiro S, Rikiya N, et al, Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients, European Journal of Radiology,2006, 60:270-274
[39]George ML, Dzik-Jurasz AS, Padhani AR, et al. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg 2001;88:1628-36.
[40]Mayr NA, Yuh WTC, Zheng J, et al. Prediction of tumor control in patients with cervical cancer:analysis of combined volume and dynamic enhancement pattern by MR imaging. Am J Roentgenol,1998; 170:177-82.
[41]Gossmann A, Helbich TH, Kuriyama N, et al. Dynamic contrast enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme. J Magn Reson Imaging 2002;15:233-40.
[42]Boss EA, Massuger LF, Pop LA, et al. Post-radiotherapy contrast enhancement changes in fast dynamic MRI of cervical carcinoma.J Magn Reson Imaging 2001;13:600-6.
[43]Baba Y, Yamashita Y, Onomichi M. Dynamic MR imaging and radiotherapy. Magn Reson Med Sci 2002;1:32-7.
[44]Baura A, Huber A, Arbogast S, et al, Diffusion weighted imaging of tumor recurrencies and post therapeutical soft tissue changes in humans, Eur Radiol,2001, 5:828-833.
[45]Silun Wang, Ed X. Wu, Deqiang Qiu, et al Longitudinal Diffusion Tensor Magnetic Resonance Imaging Study of Radiation-Induced White Matter Damage in a Rat Model Cancer Res 2009; 69:(3):1190-1198
[46]Nuri CC, Canan C,Begumhan B,Diffusion-weighted MR imaging in postoperative follow-up:Reliability for detection of recurrent cholesteatoma,European Journal of Radiology,2009 Feb 19. [Epub ahead of print]
[47]孔琳,周正荣,张有望,鼻咽癌放射治疗后颞叶损伤的质子磁共振波谱表现[J],中 华放射肿瘤学杂志,2004；13(12)：252-255
[48]Weybright P, Sundgren PC,Maly P, et al. Differentiationbetween brain tumor recurrence and radiation injury usingMR spectroscopy [J]. AJR Am J Roentgenol, 2005; 185(6):1471-1476
[49]Takeda M, Akiba H, Yama N, et al, Value of multisectional fast contrast-enhanced MR imaging in patients with elevated PSA levels after radical prostatectomy. Am J Roentgenol 2002; 178 (suppl.):97.
[50]Mark A Zahra, Kieren G Hollingsworth, Evis Sala, Dynamic contrast-enhanced MRI as a predictor of tumor response to radiotherapy, oncology. Lancet 2007,18 (1): 63-74
[51]Roberto A, Anwar R.P, Clare Allen, et al, Dynamic contrast enhanced MRI in prostate cancer, European Journal of Radiology,2007,63:335-350
[52]Barajas RF Jr, Chang JS, Segal MR, et al, Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility weighted contrast-enhanced perfusion MR imaging. Radiology.2009,253(2):486-96
[53]Dao TH, Rahmouni A, Campana F, et al, Tumor recurrence versus fibrosis in the irradiated breast:differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 1993;187:751-5.
[54]Hawnaur JM, Zhu XP, Hutchinson CE, Quantitative dynamic contrast enhanced MRI of recurrent pelvic masses in patients treated for cancer. Br J Radiol 1998;71:1136-1142.
[55]Kinkel K, Tardivon AA, Soyer P, et al, Dynamic contrast-enhanced subtraction versus T-2 weighted spin-echo MR imaging in the follow up of colorectal neoplasms:a prospective study of 41 patients. Radiology 1996;200:453-8.
[56]Cheng Li, Zhen-sheng Liu, Xian-mao Du, et al, Clinical Value of Whole-body Magnetic Resonance Diffusion Weighted Imaging on Detection of Malignant Metastases, Chinese medical sciences journal,2009,24(2):112-116.
[57]Behnaz Goudarzia, Riwa Kishimotoa, Shuhei Komatsua, et al, Detection of bone metastases using diffusion weighted magnetic resonance imaging:comparison with 11C-methionine PET and bone scintigraphy, Magnetic Resonance Imaging,2010, 28:372-379
[58]Sumi M, Sakihama N, Sumi T,et, al, Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. Am J Neuro radiology 2003;24:1627-1634.
[59]Akduman E1, Momtahen AJ, Balci NC, et al, Comparison between malignant and benign abdominal lymph nodes on diffusion-weighted imaging. Acad Radiol 2008;15:641-646.
[60]Bohyun Kim, Richard C. Semelka, Susan M. et al, Bladder Tumor Staging: Comparison of Contrast-enhanced CT, Ti-and T2-weighted MR Imaging, Dynamic Gadolinium-enhanced Imaging, and Late Gadolinium-enhanced Imaging, Radiology, 2004,193:239-245
[61]Wallengren N.O, Stig Holtas, Ake Andre'n-Sandberg, Rectal Carcinoma:Double-Contrast MR Imaging for Preoperative Staging, Radiology,2000; 215:108-114
[62]B. Nicolas Bloch, Edna Furman-Haran, Thomas H. Helbich, et al, Prostate Cancer: Accurate Determination of Extracapsular Extension with High-Spatial-Resolution Dynamic Contrast enhanced and T2-weighted MR Imaging-Initial Results Radiology,2007,245 (1):176-185.
[2]刘利兵,于军,张学策,等,新西兰兔烫伤模型的建立,第四军医大学学报,2009,30(1)：86-88.
[3]李荟元,刘建波.在瘢痕研究中建立动物模型的探索[J].中华创伤杂志,2001,17：190-192.
[4]张彤,夏群力,郑捷,一种增生性瘢痕动物模型的建立,中国皮肤性病学杂志,2008,22(3)：146-148.
[5]Dirk A., Hans J, Alf theisen, et al, Standardized qualitative evaluation of scar tissue properties in an animal wound healing model, Wound REP REG 2003;11:150-157.
[6]Joon Woo Lee, Woo Kyung Moon, Hanns-Joachim Weinmann, et. Al, Contrast-enhanced MR Imaging of Postoperative Scars and VX2 Carcinoma in Rabbits:Comparison of Macromolecular Contrast Agent and Gadopentetate Dimeglumine, Radiology,2003,229 (1):132-139
[7]M Hardy, The biology of scar formation, physical therapy,1989,69(12):1014-1024.
[8]Xinhong Lim, Ichiro T, Tomoko Tateya, et al, Immediate inflammatory response and scar formation in wound vocal folds, Rhinology and Laryngology,2006,115 (12):921-929.
[9]Willem M., Monica C.T., Magda M.W., et al, Potential cellular and molecular causes of hypertrophic scar formation, burns,2009,35:15-29
[10]Steven R. Beanes, Catherine Dang,et al, Skin repair and scar formation:the central role of TGF-β,Cambridge University Press expert reviews in molecular medicine, 2003,5(3):1-11.
[11]李玉林主编,病理学,北京,人民卫生出版社第7版,2008.01,22-23.
[12]王西樵,刘英开,毛志刚,等,增生性瘢痕中成纤维细胞生物学功能变化与微血管病理改变的研究,创伤外科杂志,2007,9(4)：311-314.
[1]李广帅,陈言汤,牛扶幼等,病理性瘢痕的发病机制,郑州大学学报,2006.41(6)：1025.1027.
[2]3.Maureen Hardy, The biology of scar formation, Physical Therapy,1989, 69 (12):1014-1024.
[3]Nonomura Y, Yasumoto M, Yoshimura R, et, al, Relationship between bone marrow cellularity and apparent diffusion coefficient, J Magn Reson Imaging,2001,13: 757-760.
[4]Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions:application to diffusion and perfusion in neurologic disorders.Radiology,1986,161, (2):401-407;
[5]Thomas DL, Lythgoe MF, Pell GS, et al. The measurement of diffusion and perfusion in biological systems using magnetic resonance imaging. Phys Med Biol,2000, 45(8):97-138;
[6]曾洪武,王培军,磁共振扩散加权与弥散张量成像原理分析及比较,中国医学影像技术,2005,21(12)：1945-1947.
[7]Kucharczy J, Roberts T, Moseley EE, et al. Contrast-enhanced perfusion-sensitive MR imaging in the diagnosis of cerebrovascular disorders [J].Magn Reson Imaging,1993,3 (1):241-245.
[8]De-Cresp igny AJ, Howard D, DA rceuil H, et al. Dynamic contrast enhanced MRI of Implanted VX2 tumors in rabbit muscle:Comparison of Gd-DTPA and NMS60 [J]. Magn Reson Imaging,1999,17:1297.
[9]邢宁,蔡祖龙,赵绍宏,等,孤立性肺结节的灌注曲线分析,中国医学影像杂志,2009,17：89-91.
[10]Verstraete KL, Deene Y, Roels H,et al, Benign and malignant musculoskeletal lesions:dynamic contrast-enhanced MR imaging-parametric "first-pass" imaging depict tissue vascularization and perfusion[J]. Radiology,1994,192 (3):835-843.
[11]Aslihan S, Elif Ayanoglu, Nihat Kodalli, et al, Dynamic contrast-enhanced MRI in the differentiation of post treatment fibrosis from recurrent carcinoma of the head and neck, Journal of Clinical Imaging,2005,29:307-312
[1]李克、于同刚,磁共振波谱技术在肌骨疾病中的应用,中国医学计算机成像杂志,2003,9(5)：332-337.
[2]刘红军,张云亭,刘松龄等.高级别星形细胞瘤与脑单发转移瘤的1H-MRS鉴别.放射学实践,2004,19(3)：183-186.
[3]张磊,金真,刘彦君等.肌细胞内脂质与胰岛素抵抗关系的1H-MRS研究.放射学实践,2005,20(2)：106-109；
[4]姚宏伟,高秀香,赵梅仙,等,傅里叶变换红外光谱与核磁共振波谱对结直肠 癌诊断价值的初步研究,中国微创外科杂志,2009,9(1)：59-61.
[5]Mueller-Lisse UG, Scherr MK, Klinikumder U.M, et, al, Proton MRS of the prostate, Eur J Radiol,2007;63 (3):351-360.
[6]Jurgen Machanna, Norbert Stefan, Fritz Schick,1H MR spectroscopy of skeletal muscle, liver and bone marrow, Eur J Radiol,2008,67 (2):275-284
[7]Brechtel K, Jacob S, Machann J, et al. Acquired Generalized Lipoatrophy(AGL): Highly Selective MR Lipid Imaging and Localized 1H-MRS[J]. J Magn Reson Imaging,2000,12(2):306-310;
[8]Towner RA, Foley LM, Painter DM, et al. Hepatocarcinogenesis tumor grading correlated wit h in vivo image guided 1H-NMR spect roscopy in a rat model. Toxicol Appl Pharmacol,2005,207:237-244.
[9]Ting YL, Sherr D, Degani H. Variations in energy and phospholipids metabolism in normal and cancer human mammary epithelial cells. Anticancer Res 1996; 16:1381-1388.
[10]Jackowski S. Cell cycle regulation.of membrane phospholipids metabolism. J Biol Chem 1996;271(34):20219-22.
[11]Rutkowski T, Tarnawski R, Sokol M, et al,1H-MR spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors. Int J Radiat Oncol Biol Phys,2003;56:1381-13899.
[12]Hyeon-Man B, Hon J. Y, Jeon-Hor C, et al, Quantitative correlation between 1H MRS and dynamic contrast-enhanced MRI of human breast cancer, Magnetic Resonance Imaging,2008,26:523-531
[13]Therese S, Kathrine R, Dag R.O, Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion weighted magnetic resonance imaging in a colorectal tumor model, Radiotherapy and Oncology,2007,85(2):187-194.
[1]Peter Boyle, Bernard Levin, http://www.iarc.fr/en/publications. World Cancer Report 2008.
[2]Thomas DL, Lythgoe MF, Pell GS, et al. The measurement of diffusion and perfusion in biological systems using magnetic resonance imaging. Phys Med Biol,2000, 45(8):97-138
[3]Cercignani M, Horsfield MA. The physical basis of diffusion weighted MRI. J Neurol Sci,2001,186[Supply 1]:11-14
[4]Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions:application to diffusion and perfusion in neurologic disorders.Radiology,1986,161, (2):401-407;
[5]Thomas DL, Lythgoe MF, Pell GS, et al. The measurement of diffusion and perfusion in biological systems using magnetic resonance imaging. Phys Med Biol,2000, 45(8):97-138;
[6]Brandao LA, Domingues RC著,刘筠主译.脑磁共振波谱成像,[M].天津：天津科技翻译出版公司,2005：2-5.
[7]Baslow MH, Suckow RF, Hungund BL. Effects of ethanol and of alcohol dehydrogenase inhibitors on the reduction of N-acetylaspartate levels of brain in mice in vivo:a search for substances that may have therapeutic vlaue in the treatmetn of Canavan disease. J Inherit Metab Dis,2000,23:684
[8]Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors:a multicenter study[J]. J Neurosurg,1996,84:449-548;
[9]齐滋华,李传福,马祥兴,等,3.0T31P-MRS对骨与软组织肿瘤的诊断价值,实用放射学杂志,2008,24(12)：1643-1647.
[10]Maris J, EvansA, Mclaughlin A, et al.31 P-NMR spectroscopic investigation of human neuroblastoma in situ[J]. N Engl JMed,1986,312 (23):1500-1505.
[11]吕衍春,孟悛非,磁共振灌注成像的原理及其在肿瘤诊断中的应用,国外医学临床放射学分册,1999,6：341-345.
[12]Koenraad L. V, Yves D. D, MSc H. Roels, et al, Benign and Malignant Musculoskeletal Lesions:Dynamic Contrast-enhanced MR Imaging Parametric "First-Pass" Images Depict Tissue Vascularization and Perfusion, Radiology 1994, 192 (3); 192:835-843
[13]Wang W, Campiche M, Micro vasculature of human colorectal epithelial tumor:an electron microscopic study, Vichows Arch A Pathol Anat Histopathol,1982; 397: 131-147.
[14]Jackson A, Kassner A, Zhu XP, Li KL. Reproducibility of T2* blood volume and vascular tortuosity maps in cerebral gliomas. J Magn Reson Imaging, 2001;14:510-516.
[15]Tanabel JL,Yongbi M, Branch C,et al. MR perfusion imaging in human brain using the UN-FAIR technigue:un-inverted flow-sensitive alternating inversion recovery.J Magn Reson Imaging,1999,9:761
[16]Bettina Siewert, Gottfried Schlaug, Robert R Edelman, et al, Comparison of EPISTAR and T sub 2*-weighted gadolinium-enhanced perfusion imaging in patients with acute cerebral ischemia, Neurology.1997,48 (3):673-679.
[17]TM Talavage, WB Edmister, PJ Ledden, et al, Quantitative assessment of auditory cortex responses induced by imager acoustic noise", Human Brain Mapping,1999, 7 (2):79-88,.
[18]Pickles MD, Gibbs P, Lowry M, Turnbull LW. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 2006;24:843-847.
[19]Zhao M, Pipe JG, Bonnett J, et al. Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. Br J Cancer 1996;73:61-4.
[20]Le Bihan D, Breton E, Lallemand D, et al.Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168:497-505.
[21]Chenevert TL, McKeever PE, Ross BD. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res1997;3:1457-66.
[22]Lemaire L, Howe FA, Rodrigues LM, et al. Assessment of induced rat mammary tumour response to chemotherapy using the apparent diffusion coefficient of tissue water as determined by diffusion-weighted 1H-NMR spectroscopy in vivo. MAGMA 1999;8:20-26.
[23]Moffat BA, Chenevert TL, Lawrence TS, et al. Functional diffusion map:a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA 2005; 102:5524-9.
[24]Theilmann RJ, Borders R, Trouard TP,et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 2004;6:831-839.
[25]Dzik-Jurasz A, Domenig C, George M, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. The Lancet 2002;360:307-308.
[26]Vanessa N, Scott IS, Fiona J, et al, Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer Gynecologic Oncology, (2008)111:213-220
[27]Khong PL, Kwong DL, Chan GC, et al, Diffusion tensor imaging for the detection and quantification of treatment induced white matter injury in children with medulloblastoma:a pilot study. AJNR 2003;24(4):734-40.
[28]Khong PL, Lucullus H.T. Leung, Amy S.M, et al, White Matter Anisotropy in Post-Treatment Childhood Cancer Survivors:Preliminary Evidence of Association With Neurocognitive Function J Clin Oncol,2004,24 (2):884-890.
[29]DJ Manton, A Chaturvedi, A Hubbard,et al, Neoadjuvant chemotherapy in breast cancer:early response prediction with quantitative MR imaging and spectroscopy, Br J Cancer,2006,94 (3):427-435
[30]Isobe T,Matsumura A, Anno I, et al. Changes in 1H-MRS in glioma patients before and after irradiation:the significance of quantitative analysis of choline-containing compounds[J]. No Shinkei Geka,2003; 31 (2):167-172.
[31]Tzika AA, ZurakowskiD, Poussaint TY, et al. Proton magnetic spectroscop ic imaging of the child's brain:the response of tumors to treatment [J]. N euroradiology, 2001;43(6):169-177.
[32]杜泽涵,茹祥斌,李光玉,等.紫杉醇治疗小鼠S180肉瘤的体内31P-MRS研究[J].波谱学杂志,1999,16(1)：5-10.
[33]Moller HE, Vermathen P, Rummeny E, et al. In vivo 31P-MRS of human musculoskeletal tumors as a measure of response to chemotherapy. NMR Biomed, 1996,9(8):347-358;
[34]Elena V. B, Shu Li, Anna M. B, et al, Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers, Journal of Controlled Release,2010, Jan 13. [E pub ahead of print].
[35]T.M. Krupka, B.D. Weinberg, H. Wu, et al, Effect of intratumoral injection of carboplatin combined with pluronic P85 or L61 on experimental colorectal carcinoma in rats, Exp. Biol. Med. (Maywood),2007,232(7):950-957.
[36]Jacquemier JD, Penault-Llorca FM, Bertucci F, et al. Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy:a multiparametric and immuno histochemical analysis. J Pathol 1998;184:130-5.
[37]Van Der Woude HJ, Bloem JL, Verstraete KL, et al. Osteosarcoma and Ewing sarcoma after neoadhuvant chemotherapy:value of dynamic MR imaging in detecting viable tumor before surgery. AJR,1995,65:593-598;
[38]Takeshi N, Masahiro S, Rikiya N, et al, Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients, European Journal of Radiology,2006, 60:270-274
[39]George ML, Dzik-Jurasz AS, Padhani AR, et al. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg 2001;88:1628-36.
[40]Mayr NA, Yuh WTC, Zheng J, et al. Prediction of tumor control in patients with cervical cancer:analysis of combined volume and dynamic enhancement pattern by MR imaging. Am J Roentgenol,1998; 170:177-82.
[41]Gossmann A, Helbich TH, Kuriyama N, et al. Dynamic contrast enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme. J Magn Reson Imaging 2002;15:233-40.
[42]Boss EA, Massuger LF, Pop LA, et al. Post-radiotherapy contrast enhancement changes in fast dynamic MRI of cervical carcinoma.J Magn Reson Imaging 2001;13:600-6.
[43]Baba Y, Yamashita Y, Onomichi M. Dynamic MR imaging and radiotherapy. Magn Reson Med Sci 2002;1:32-7.
[44]Baura A, Huber A, Arbogast S, et al, Diffusion weighted imaging of tumor recurrencies and post therapeutical soft tissue changes in humans, Eur Radiol,2001, 5:828-833.
[45]Silun Wang, Ed X. Wu, Deqiang Qiu, et al Longitudinal Diffusion Tensor Magnetic Resonance Imaging Study of Radiation-Induced White Matter Damage in a Rat Model Cancer Res 2009; 69:(3):1190-1198
[46]Nuri CC, Canan C,Begumhan B,Diffusion-weighted MR imaging in postoperative follow-up:Reliability for detection of recurrent cholesteatoma,European Journal of Radiology,2009 Feb 19. [Epub ahead of print]
[47]孔琳,周正荣,张有望,鼻咽癌放射治疗后颞叶损伤的质子磁共振波谱表现[J],中 华放射肿瘤学杂志,2004；13(12)：252-255
[48]Weybright P, Sundgren PC,Maly P, et al. Differentiationbetween brain tumor recurrence and radiation injury usingMR spectroscopy [J]. AJR Am J Roentgenol, 2005; 185(6):1471-1476
[49]Takeda M, Akiba H, Yama N, et al, Value of multisectional fast contrast-enhanced MR imaging in patients with elevated PSA levels after radical prostatectomy. Am J Roentgenol 2002; 178 (suppl.):97.
[50]Mark A Zahra, Kieren G Hollingsworth, Evis Sala, Dynamic contrast-enhanced MRI as a predictor of tumor response to radiotherapy, oncology. Lancet 2007,18 (1): 63-74
[51]Roberto A, Anwar R.P, Clare Allen, et al, Dynamic contrast enhanced MRI in prostate cancer, European Journal of Radiology,2007,63:335-350
[52]Barajas RF Jr, Chang JS, Segal MR, et al, Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility weighted contrast-enhanced perfusion MR imaging. Radiology.2009,253(2):486-96
[53]Dao TH, Rahmouni A, Campana F, et al, Tumor recurrence versus fibrosis in the irradiated breast:differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 1993;187:751-5.
[54]Hawnaur JM, Zhu XP, Hutchinson CE, Quantitative dynamic contrast enhanced MRI of recurrent pelvic masses in patients treated for cancer. Br J Radiol 1998;71:1136-1142.
[55]Kinkel K, Tardivon AA, Soyer P, et al, Dynamic contrast-enhanced subtraction versus T-2 weighted spin-echo MR imaging in the follow up of colorectal neoplasms:a prospective study of 41 patients. Radiology 1996;200:453-8.
[56]Cheng Li, Zhen-sheng Liu, Xian-mao Du, et al, Clinical Value of Whole-body Magnetic Resonance Diffusion Weighted Imaging on Detection of Malignant Metastases, Chinese medical sciences journal,2009,24(2):112-116.
[57]Behnaz Goudarzia, Riwa Kishimotoa, Shuhei Komatsua, et al, Detection of bone metastases using diffusion weighted magnetic resonance imaging:comparison with 11C-methionine PET and bone scintigraphy, Magnetic Resonance Imaging,2010, 28:372-379
[58]Sumi M, Sakihama N, Sumi T,et, al, Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. Am J Neuro radiology 2003;24:1627-1634.
[59]Akduman E1, Momtahen AJ, Balci NC, et al, Comparison between malignant and benign abdominal lymph nodes on diffusion-weighted imaging. Acad Radiol 2008;15:641-646.
[60]Bohyun Kim, Richard C. Semelka, Susan M. et al, Bladder Tumor Staging: Comparison of Contrast-enhanced CT, Ti-and T2-weighted MR Imaging, Dynamic Gadolinium-enhanced Imaging, and Late Gadolinium-enhanced Imaging, Radiology, 2004,193:239-245
[61]Wallengren N.O, Stig Holtas, Ake Andre'n-Sandberg, Rectal Carcinoma:Double-Contrast MR Imaging for Preoperative Staging, Radiology,2000; 215:108-114
[62]B. Nicolas Bloch, Edna Furman-Haran, Thomas H. Helbich, et al, Prostate Cancer: Accurate Determination of Extracapsular Extension with High-Spatial-Resolution Dynamic Contrast enhanced and T2-weighted MR Imaging-Initial Results Radiology,2007,245 (1):176-185.